The WHO released new guidance on GLP-1 medications for adults with obesity, recommending their long-term, continuous use when ...

The World Health Organization (WHO) has finally made its recommendations on using glucagon-like peptide-1 (GLP-1) ...

Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, ...

Lilly and Novo are facing off in the lucrative global obesity market, which analysts expect to reach $100 billion by the end ...

New WHO guidance calls for a worldwide obesity treatment “ecosystem” to ensure that GLP-1 weight-loss drugs are used fairly ...

A first-of-its-kind oral drug boosts muscle metabolism to improve blood sugar and body composition is now headed into larger clinical trials. Lowering blood sugar and increasing fat burning – without ...

The World Health Organization is officially backing popular weight-loss drugs like Ozempic and Wegovy. The WHO published new guidelines about glucagon-like peptide-1 (GLP-1) medications in the medical ...